v3.26.1
Segment Reporting
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
We operate and manage our business as one reportable and operating segment. Our chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance based on consolidated net loss, as is reported in our condensed consolidated statements of operations.
Our long-lived assets are based in the United States and Switzerland. Long-lived assets are comprised of property and equipment. As of March 31, 2026 and December 31, 2025, property and equipment based in the United States was $41.3 million and $39.7 million, respectively. As of March 31, 2026 and December 31, 2025, property and equipment based in Switzerland was $219.4 million and $217.7 million, respectively.
This following table presents segment operation results for the three months ended March 31, 2026 and 2025:
Three Months Ended
March 31,
20262025
Operating expenses:
Research and development - external costs (1)
$256,432 $103,806 
Research and development - internal costs (2)
56,347 44,328 
General and administrative
33,071 32,659 
Total operating expenses
$345,850 $180,793 
Total other income, net
25,228 40,075 
Net loss
$320,622 $140,718 
____________________________________________________________
(1)Research and development - external costs consist primarily of product and clinical development, research, facility, depreciation, professional and consulting services expenses attributed to the research and development departments.
(2)Research and development - internal costs consist of internal employee costs including stock-based compensation expenses.